Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-08
2006-08-08
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S279100
Reexamination Certificate
active
07087628
ABSTRACT:
This invention relates to a series of N-heterocyclyl hydrazides of Formula I,and pharmaceutical compositions containing them. The compounds of the invention have neurotrophic activity and are useful in the treatment and prevention of neuronal disorders such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis diabetic neuropathy and Bell's palsy.
REFERENCES:
patent: 4665173 (1987-05-01), Klayman et al.
patent: 4694004 (1987-09-01), Nakaguti et al.
patent: 6271247 (2001-08-01), Monge Vega et al.
patent: 6555542 (2003-04-01), O'Connor et al.
patent: WO 01 04090 (2001-01-01), None
patent: WO 01 04091 (2001-01-01), None
PCT International Search Report dated Dec. 17, 2002.
Lanter James
Macielag Mark
Sui Zhihua
Anderson Rebecca
Ortho-McNeil Pharmaceutical , Inc.
Saeed Kamal A.
LandOfFree
N-heterocyclyl hydrazides as neurotrophic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-heterocyclyl hydrazides as neurotrophic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-heterocyclyl hydrazides as neurotrophic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3621640